CAP - Consortium to Alleviate PTSD - STVHCS Neuroimaging Core

CAP - 减轻 PTSD 联盟 - STVHCS 神经影像核心

• 批准号: 8770323
• 负责人: PETER Thornton FOX
• 金额: --
• 依托单位: SOUTH TEXAS VETERANS HEALTH CARE SYSTEM
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-01 至 2019-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8770323
• 关键词: Address; Advisory Committees; Alcohol or Other Drugs use; Animals; Biological Markers; Biological Models; Characteristics; Clinical Trials; Cognitive Therapy; Communication; Data; Diagnosis; Diagnostic; Diagnostic Sensitivity; Disclosure; Electronics; Employee Strikes; Ensure; Epidemiology; Equilibrium; Etiology; Evaluation; Exposure to; Fostering; Foundations; Foxes; Functional Imaging; Functional Magnetic Resonance Imaging; Functional disorder; Funding; Future; Genomics; Goals; Government; Guidelines; Headache; Image; Image Analysis; Impairment; Individual; Institutes; Institution; Intervention; Ketamine; Learning; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mental Depression; Mental Health; Meta-Analysis; Methods; Military Personnel; Modeling; Neurobiology; Neurocognitive; Pain; Pathology; Personal Satisfaction; Persons; Pharmacotherapy; Positioning Attribute; Post-Traumatic Stress Disorders; Postdoctoral Fellow; Prevention; Prevention strategy; Preventive; Principal Investigator; Printing; Procedures; Process; Productivity; Proteomics; Protocols documentation; Psychometrics; Publications; Rehabilitation therapy; Research; Research Infrastructure; Research Personnel; Research Project Grants; Research Support; Review Committee; Role; Services; Site; Sleep disturbances; Sleeplessness; Stress; Structure; Suicide; System; Teleconferences; Tracer; Training; Veterans; Work; base; behavioral health; combat; cost; data acquisition; design; imaging modality; improved; interest; meetings; member; multidisciplinary; neuroimaging; neurophysiology; novel; organizational structure; outcome forecast; physical conditioning; post-traumatic stress; prevent; prognostic; quality assurance; research study; response; success; tomography; treatment response

Neuroimaging Core The Neuroimaging Core builds upon a strong foundation developed over the past four years as a STRONG STAR core. Dr. Fox is currently Director of the STRONG STAR Neuroimaging Core; he will continue in this role for the STRONG STAR-CAP, being joined by Dr. Krystal as Co-Director. The overall objective of the Neuroimaging Core is to foster the use of advanced neuroimaging methods in the study of PTSD and related conditions for the purposes of (1) investigating the underlying pathology (using structural imaging) and pathophysiology (using functional imaging); (2) assessing and enhancing the diagnostic sensitivity of imaging methods; (3) investigating the neurophysiology of treatment response (image-based response assessment); and (4) ensuring comparability of imaging data acquisition and pre-processing between sites. Neuroimaging methods utilized include structural and functional magnetic resonance imaging (MRI and fMRI), magnetic resonance spectroscopy (MRS), and position emission tomography (PET). These methods are used in the context of extensive neurocognitive assessments focused on evaluation of PTSD-related impairments, with psychometric scores being used as probes for voxel-wise and region-of-interest-based analyses. The Neuroimaging Core provides standardized core image-acquisition and image-analysis protocols (both structural and functional), as well as developing project-specific neuroimaging probes. In the ongoing STRONG STAR Consortium, neuroimaging imaging assessments focused on modeling the system-level effects of PTSD (e.g., Ramage et al., 2012) and characterizing the mechanisms of action of cognitive and behavioral therapy. In the current proposal, emphasis is placed on the mechanisms of action of Prolonged Exposure (PE; project 1), on pharmacotherapy (ketamine; Project 1) and on insomnia (Project 7). Previously based solely at UTHSCSA's Research Imaging Institute, the Neuroimaging Core now incorporates a second world-class neuroimaging facility, i.e., that at Yale. In doing so, the Neuroimaging Core builds upon an ongoing collaborative relationship with Yale, focused on high-field, small-animal imaging. Image-analysis capabilities at both core components are outstanding and complementary, with the Research Imaging Institute having exceptional strengths in meta- analysis and system-level modeling construction and with Yale having exceptional strengths in analysis of pharmacologic interventions and tracer-based imaging methods.

神经影像核心 神经影像核心建立在过去四年中发展的强大基础上 星核。福克斯博士目前是Start Star神经影像学核心的主任；他将继续 克里斯塔尔博士（Krystal）担任联合导演的角色，强大的星级冠军的角色。总体目标 神经影像核心是促进PTSD和相关研究中的高级神经影像学方法的使用 出于（1）研究基本病理（使用结构成像）和 病理生理学（使用功能成像）； （2）评估和增强成像的诊断灵敏度 方法; （3）研究治疗反应的神经生理学（基于图像的反应评估）；和 （4）确保位点之间的成像数据采集和预处理的可比性。神经影像学 使用的方法包括结构和功能磁共振成像（MRI和fMRI），磁性 共振光谱（MRS）和位置发射断层扫描（PET）。这些方法用于 广泛的神经认知评估的背景侧重于评估与PTSD相关的障碍，并与 心理测量评分被用作素养和基于利益区域的分析的探针。这 神经影像学核心提供标准化的核心图像刷新和图像分析协议（这两个结构性 和功能），以及开发特定项目的神经影像探针。在正在进行的强大明星中 财团，神经影像学评估的重点是建模PTSD的系统级效应（例如， Ramage等，2012），并表征了认知和行为疗法的作用机理。在 当前的建议，重点放在长期暴露的作用机理上（PE；项目1）， 药物治疗（氯胺酮；项目1）和失眠（项目7）。以前仅基于UTHSCSA的 研究成像研究所，神经影像学核心现在结合了第二个世界一流的神经影像学 设施，即在耶鲁大学。为此，神经影像核心建立在持续的协作关系的基础上 耶鲁大学专注于高场，小动物成像。两个核心组件的图像分析功能 是出色和互补的，研究成像研究所在元中具有出色的优势 分析和系统级建模构建以及耶鲁大学在分析中具有出色的优势 药理干预措施和基于示踪剂的成像方法。